Advisornet Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Advisornet Financial's JAZZ Position: Q1 2026 in Review
Advisornet Financial held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 3 shares worth $567. The position accounts for ﹤0.01% of the portfolio, ranked #2082.
Advisornet Financial first reported a position in JAZZ in Q3 2019 and has held it in 22 quarters since. The position peaked at $152K in Q4 2019. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Advisornet Financial held 3 shares of Jazz Pharmaceuticals worth $567 as of Q1 2026.
- Advisornet Financial left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Advisornet Financial's portfolio in Q1 2026, its #2082 holding.
- Advisornet Financial first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 22 quarters since.
- Advisornet Financial's Jazz Pharmaceuticals position peaked at $152K in Q4 2019.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.